Gilead closes in on second CAR-T approval in US

Gilead closes in on second CAR-T approval in US

Submitted by admin on February 11, 2020 - 10:30am
Source: 
Pharmaforum
News Tags: 
FDA
Gilead Sciences
Kite Pharma
mantle cell lymphoma
CAR-T
Headline: 
Gilead closes in on second CAR-T approval in US
snippet: 

The FDA is due to decide by 10 August whether it will approve a second CAR-T therapy from Gilead’s Kite unit intended to treat mantle cell lymphoma (MCL).

Do Not Allow Advertisers to Use My Personal information